Prospective, single-arm, multicenter clinical study of lenvatinib for adjuvant treatment of HCC patients with high risk of recurrence after hepatectomy.
Latest Information Update: 03 Aug 2020
At a glance
- Drugs Lenvatinib (Primary)
- Indications Carcinoma; Liver cancer
- Focus Therapeutic Use
- 03 Aug 2020 New trial record